Abstract
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | PLoS ONE |
| Vol/bind | 4 |
| Udgave nummer | 5 |
| Sider (fra-til) | e5469 |
| ISSN | 1932-6203 |
| DOI | |
| Status | Udgivet - 2009 |
Bibliografisk note
Keywords: Adult; Case-Control Studies; Cohort Studies; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Genotype; Glucose Tolerance Test; Glycoproteins; Haplotypes; Humans; Insulin Resistance; Male; Microsatellite Repeats; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Risk FactorsExport Date: 4 November 2009Source: ScopusArt. No.: e5469
Adgang til dokumentet
Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Variation in CHI3LI in relation to type 2 diabetes and related quantitative traits. / Rathcke, Camilla Noelle; Holmkvist, Johan; Jørgensen, Torben; Borch-Johnsen, Knut; Hansen, Torben; Pedersen, Oluf; Vestergaard, Henrik.
I: PLoS ONE, Bind 4, Nr. 5, 2009, s. e5469.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
}
TY - JOUR
T1 - Variation in CHI3LI in relation to type 2 diabetes and related quantitative traits
AU - Rathcke, Camilla Noelle
AU - Holmkvist, Johan
AU - Jørgensen, Torben
AU - Borch-Johnsen, Knut
AU - Hansen, Torben
AU - Pedersen, Oluf
AU - Vestergaard, Henrik
N1 - Keywords: Adult; Case-Control Studies; Cohort Studies; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Genotype; Glucose Tolerance Test; Glycoproteins; Haplotypes; Humans; Insulin Resistance; Male; Microsatellite Repeats; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Risk Factors Export Date: 4 November 2009Source: ScopusArt. No.: e5469
PY - 2009
Y1 - 2009
N2 - BACKGROUND: CHI3LI encoding the inflammatory glycoprotein YKL-40 is located on chromosome 1q32.1. YKL-40 is involved in inflammatory processes and patients with Type 2 Diabetes (T2D) have elevated circulating YKL-40 levels which correlate with their level of insulin resistance. Interestingly, it has been reported that rs10399931 (-329 G/A) of CHI3LI contributes to the inter-individual plasma YKL-40 levels in patients with sarcoidosis, and that rs4950928 (-131 C/G) is a susceptibility polymorphism for asthma and a decline in lung function. We hypothesized that single nucleotide polymorphisms (SNPs) or haplotypes thereof the CHI3LI locus might influence risk of T2D. The aim of the present study was to investigate the putative association between SNPs and haplotype blocks of CHI3LI and T2D and T2D related quantitative traits. METHODS/PRINCIPAL FINDINGS: Eleven SNPs of CHI3LI were genotyped in 6514 individuals from the Inter99 cohort and 2924 individuals from the outpatient clinic at Steno Diabetes Center. In cas-control studies a total of 2345 T2D patients and 5302 individuals with a normal glucose tolerance test were examined. We found no association between rs10399931 (OR, 0.98 (CI, 0.88-1.10), p = 0.76), rs4950928 (0.98 (0.87-1.10), p = 0.68) or any of the other SNPs with T2D. Similarly, we found no significant association between any of the 11 tgSNPs and T2D related quantitative traits, all p>0.14. None of the identified haplotype blocks of CHI3LI showed any association with T2D, all p>0.16. CONCLUSIONS/SIGNIFICANCE: None of the examined SNPs or haplotype blocks of CHI3LI showed any association with T2D or T2D related quantitative traits. Estimates of insulin resistance and dysregulated glucose homeostasis in T2D do not seem to be accounted for by the examined variations of CHI3LI.
AB - BACKGROUND: CHI3LI encoding the inflammatory glycoprotein YKL-40 is located on chromosome 1q32.1. YKL-40 is involved in inflammatory processes and patients with Type 2 Diabetes (T2D) have elevated circulating YKL-40 levels which correlate with their level of insulin resistance. Interestingly, it has been reported that rs10399931 (-329 G/A) of CHI3LI contributes to the inter-individual plasma YKL-40 levels in patients with sarcoidosis, and that rs4950928 (-131 C/G) is a susceptibility polymorphism for asthma and a decline in lung function. We hypothesized that single nucleotide polymorphisms (SNPs) or haplotypes thereof the CHI3LI locus might influence risk of T2D. The aim of the present study was to investigate the putative association between SNPs and haplotype blocks of CHI3LI and T2D and T2D related quantitative traits. METHODS/PRINCIPAL FINDINGS: Eleven SNPs of CHI3LI were genotyped in 6514 individuals from the Inter99 cohort and 2924 individuals from the outpatient clinic at Steno Diabetes Center. In cas-control studies a total of 2345 T2D patients and 5302 individuals with a normal glucose tolerance test were examined. We found no association between rs10399931 (OR, 0.98 (CI, 0.88-1.10), p = 0.76), rs4950928 (0.98 (0.87-1.10), p = 0.68) or any of the other SNPs with T2D. Similarly, we found no significant association between any of the 11 tgSNPs and T2D related quantitative traits, all p>0.14. None of the identified haplotype blocks of CHI3LI showed any association with T2D, all p>0.16. CONCLUSIONS/SIGNIFICANCE: None of the examined SNPs or haplotype blocks of CHI3LI showed any association with T2D or T2D related quantitative traits. Estimates of insulin resistance and dysregulated glucose homeostasis in T2D do not seem to be accounted for by the examined variations of CHI3LI.
U2 - 10.1371/journal.pone.0005469
DO - 10.1371/journal.pone.0005469
M3 - Journal article
C2 - 19421404
VL - 4
SP - e5469
JO - PLoS ONE
JF - PLoS ONE
SN - 1932-6203
IS - 5
ER -